AAT Inhibitors

AAT inhibitors, short for Alpha-1 Antitrypsin inhibitors, belong to a distinct chemical class within the realm of protease inhibitors. These molecules are primarily recognized for their role in regulating the activity of a key protease enzyme called neutrophil elastase. Neutrophil elastase is an enzyme that plays a crucial role in the immune system, particularly in the defense against bacterial infections. However, when its activity becomes dysregulated, it can lead to tissue damage and inflammation. AAT inhibitors are thus designed to modulate the activity of neutrophil elastase by binding to it and inhibiting its proteolytic function. This class of inhibitors typically includes small molecules or peptides that are structurally designed to fit into the active site of neutrophil elastase, preventing it from cleaving its target proteins. AAT inhibitors are essential for maintaining the delicate balance between the need for immune defense and the protection of healthy tissues. When neutrophil elastase is left unchecked, it can cause tissue damage in various organs, particularly the lungs and liver. AAT inhibitors are instrumental in preventing such damage by binding to and neutralizing the excessive activity of neutrophil elastase. They are not only crucial for normal immune function but also play a role in conditions where this balance is disrupted, such as certain genetic disorders like alpha-1 antitrypsin deficiency. These inhibitors are an integral part of the body's innate defense mechanisms, helping to prevent the collateral damage that can occur during immune responses.